Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) fell 4.5% on Wednesday . The company traded as low as $0.79 and last traded at $0.79. 613,793 shares traded hands during trading, a decline of 2% from the average session volume of 624,301 shares. The stock had previously closed at $0.83.
Curaleaf Price Performance
The firm has a 50 day simple moving average of $0.87 and a 200-day simple moving average of $1.17. The company has a market cap of $546.65 million, a PE ratio of -2.66 and a beta of 0.60. The company has a quick ratio of 0.70, a current ratio of 1.41 and a debt-to-equity ratio of 1.08.
Curaleaf (OTCMKTS:CURLF - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. As a group, research analysts predict that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current fiscal year.
Curaleaf Company Profile
(
Get Free Report)
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Curaleaf, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.
While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
